NR4A1 and ovarian cancer: No important differences in age, family history of breast and/or ovarian cancer, surgery modality, months since diagnosis, breast density, initial tumor histology, stage, or hormone receptor status were noted between the two groups, although a nonsignificant higher number of patient with triple negative cancers was observed in the group that received A-MRI.